Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 33,562 shares at $105.30 ($3.5M) on 2025-09-02, disclosed to the SEC on 2025-09-04.
Scheduled sale ($3.5M) by Chief Technical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.30 | 16,781 | $1.8M | 50.0% |
| 2 | $105.30 | 16,781 | $1.8M | 50.0% |
| Total | $105.30 avg | 33,562 | $3.5M | 100% |
| Filing → |
| RYTM | SELL | 2025-10-30 | $648K | — | Filing → |
| RYTM | SELL | 2025-10-20 | $3.2M | — | Filing → |
| RYTM | SELL | 2025-08-25 | $838K | — | Filing → |